Skip to content

Clinical trial of homeopathic medicine arsenic album as add on therapy in hospitalized patients admitted with Covid 19 disease.

â??Clinical trial to evaluate the efficacy of Homeopathic medicine Arsenicum album as add on therapy in treating hospitalized patients diagnosed with Covid 19.â??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027615
Enrollment
200
Registered
2020-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Arsenicum album: Arsenicum album Homeopathic medicine in 30x 200 and 1m potency (Doses as per Homeopathic Pharmacopia) Control Intervention1: Standard line treatment for Covid 19: Ant

Sponsors

Dr Vishal Narwane
Lead Sponsor
Dr Anand Nikalje
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects male or female age 18 to 75 years. 2) Laboratory confirmed cases of sars-cov-2 positive 3) Signs of respiratory failure requiring oxygen therapy 4) Negative results for pregnancy 5) Subjects or relatives are willing and capable of signing the consent.

Exclusion criteria

Exclusion criteria: 1) Autoimmune disease 2) Subject under-vent major surgery 3) Pregnant or lactating females

Design outcomes

Primary

MeasureTime frame
Proportion of patients achieving viral clearance or symptoms free within 28 days, upon administration of treatment for 28 days in patients. 1 by doing investigations of inflammatory markers 2 weaning from ventilation 3 weaning oxygen of patientsTimepoint: Assessment on daily basis, and investigatory assessment on 1st day, 4th day, 7th day, 11th day and on discharge.

Secondary

MeasureTime frame
1) Proportion of patients showing improvement in clinical condition as defined by WHO ordinal scale of clinical improvement in patients on day5, day10, day15, day20,day25 and day 28. 2) Time to wean of oxygen supply (time to return to normal or baseline oxygen saturation) in patients within 28 days. 3) Proportion of patients requiring invasive ventilator within 28days. 4) Proportion of patients with mortality within 28 days in patients. Timepoint: on 1st day of admission then 4th day, 7th day, 11th day and on discharge day.

Countries

India

Contacts

Public ContactDr Vishal Harilal Narwane

mgm mcri hospital and college

nvishu007@yahoo.co.in9405292852

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026